Uploaded November 2026 | Updated November 2026, 1 day ago
Hear from Viet Le, DMSc, PA-C, FACC, FAHA, HF- Cert! 🎥
Lp(a) HORIZON, presented at #ScientificSessions26 showed Pelacarsen substantially lowered lipoprotein(a) but did not reduce risk of MACE compared to placebo in patients on guideline-directed medical therapy for secondary prevention of CVD.
Hear from Viet Le, DMSc, PA-C, FACC, FAHA, HF- Cert! 🎥
Lp(a) HORIZON, presented at #ScientificSessions26 showed Pelacarsen substantially lowered lipoprotein(a) but did not reduce risk of MACE compared to placebo in patients on guideline-directed medical therapy for secondary prevention of CVD.










